On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.34 USD | +0.17% | -4.96% | -17.48% |
05-22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
05-22 | Bristol-Myers Squibb Announces Strategies to Improve Access to Medicines | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.48% | 85.83B | |
+37.74% | 723B | |
+34.95% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.53% | 244B | |
+9.72% | 208B | |
-4.58% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company